Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-21-003182
Filing Date
2021-03-16
Accepted
2021-03-16 16:30:28
Documents
1
Period of Report
2021-03-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-51908.html 4  
1 PRIMARY DOCUMENT marketforms-51908.xml 4 9883
  Complete submission text file 0001214659-21-003182.txt   11404
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Issuer) CIK: 0000791908 (see all company filings)

EIN.: 522154066 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XOMA LTD 2910 SEVENTH ST. BERKELEY CA 94710
Business Address
VAN NESS W DENMAN (Reporting) CIK: 0001221676 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39801 | Film No.: 21746168